Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis

J. H. Yeh, S. H. Wang, P. J. Chien, C. M. Shih, H. C. Chiu

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: The effect of plasmapheresis on cytokine levels in patients with myasthenia gravis (MG) has not been well established. Methods: Cytokine levels were measured in 19 patients with MG before and after treatment with one course of double-filtration plasmapheresis (DFP). The control group comprised 6 age- and sex-matched healthy volunteers. Results: At baseline, patients with MG had higher levels of IL-10 than normal controls. The levels of IL-2, IL-4, IL-5, and tumor necrosis factor-α were almost undetectable in MG patients. After a single session of DFP treatment, IL-10 levels were significantly increased. After three sessions, IL-10 levels were still higher than those at baseline. Elevated IL-10 level was significantly associated with use of immunosuppressant drugs, thymectomy, and good response to DFP treatment. Conclusions: Interleukin-10 might play a crucial role in the pathogenesis and perpetuation of MG.

Original languageEnglish
Pages (from-to)1318-1322
Number of pages5
JournalEuropean Journal of Neurology
Volume16
Issue number12
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Plasmapheresis
Myasthenia Gravis
Interleukin-10
Cytokines
Serum
Thymectomy
Interleukin-5
Immunosuppressive Agents
Interleukin-4
Interleukin-2
Healthy Volunteers
Therapeutics
Tumor Necrosis Factor-alpha
Control Groups
Pharmaceutical Preparations

Keywords

  • Cytokines
  • Myasthenia gravis
  • Plasmapheresis

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis. / Yeh, J. H.; Wang, S. H.; Chien, P. J.; Shih, C. M.; Chiu, H. C.

In: European Journal of Neurology, Vol. 16, No. 12, 12.2009, p. 1318-1322.

Research output: Contribution to journalArticle

Yeh, J. H. ; Wang, S. H. ; Chien, P. J. ; Shih, C. M. ; Chiu, H. C. / Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis. In: European Journal of Neurology. 2009 ; Vol. 16, No. 12. pp. 1318-1322.
@article{ea7dec05445c4d94a67d1b27700cca8b,
title = "Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis",
abstract = "Background: The effect of plasmapheresis on cytokine levels in patients with myasthenia gravis (MG) has not been well established. Methods: Cytokine levels were measured in 19 patients with MG before and after treatment with one course of double-filtration plasmapheresis (DFP). The control group comprised 6 age- and sex-matched healthy volunteers. Results: At baseline, patients with MG had higher levels of IL-10 than normal controls. The levels of IL-2, IL-4, IL-5, and tumor necrosis factor-α were almost undetectable in MG patients. After a single session of DFP treatment, IL-10 levels were significantly increased. After three sessions, IL-10 levels were still higher than those at baseline. Elevated IL-10 level was significantly associated with use of immunosuppressant drugs, thymectomy, and good response to DFP treatment. Conclusions: Interleukin-10 might play a crucial role in the pathogenesis and perpetuation of MG.",
keywords = "Cytokines, Myasthenia gravis, Plasmapheresis",
author = "Yeh, {J. H.} and Wang, {S. H.} and Chien, {P. J.} and Shih, {C. M.} and Chiu, {H. C.}",
year = "2009",
month = "12",
doi = "10.1111/j.1468-1331.2009.02729.x",
language = "English",
volume = "16",
pages = "1318--1322",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Changes in serum cytokine levels during plasmapheresis in patients with myasthenia gravis

AU - Yeh, J. H.

AU - Wang, S. H.

AU - Chien, P. J.

AU - Shih, C. M.

AU - Chiu, H. C.

PY - 2009/12

Y1 - 2009/12

N2 - Background: The effect of plasmapheresis on cytokine levels in patients with myasthenia gravis (MG) has not been well established. Methods: Cytokine levels were measured in 19 patients with MG before and after treatment with one course of double-filtration plasmapheresis (DFP). The control group comprised 6 age- and sex-matched healthy volunteers. Results: At baseline, patients with MG had higher levels of IL-10 than normal controls. The levels of IL-2, IL-4, IL-5, and tumor necrosis factor-α were almost undetectable in MG patients. After a single session of DFP treatment, IL-10 levels were significantly increased. After three sessions, IL-10 levels were still higher than those at baseline. Elevated IL-10 level was significantly associated with use of immunosuppressant drugs, thymectomy, and good response to DFP treatment. Conclusions: Interleukin-10 might play a crucial role in the pathogenesis and perpetuation of MG.

AB - Background: The effect of plasmapheresis on cytokine levels in patients with myasthenia gravis (MG) has not been well established. Methods: Cytokine levels were measured in 19 patients with MG before and after treatment with one course of double-filtration plasmapheresis (DFP). The control group comprised 6 age- and sex-matched healthy volunteers. Results: At baseline, patients with MG had higher levels of IL-10 than normal controls. The levels of IL-2, IL-4, IL-5, and tumor necrosis factor-α were almost undetectable in MG patients. After a single session of DFP treatment, IL-10 levels were significantly increased. After three sessions, IL-10 levels were still higher than those at baseline. Elevated IL-10 level was significantly associated with use of immunosuppressant drugs, thymectomy, and good response to DFP treatment. Conclusions: Interleukin-10 might play a crucial role in the pathogenesis and perpetuation of MG.

KW - Cytokines

KW - Myasthenia gravis

KW - Plasmapheresis

UR - http://www.scopus.com/inward/record.url?scp=70450159804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70450159804&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1331.2009.02729.x

DO - 10.1111/j.1468-1331.2009.02729.x

M3 - Article

C2 - 19614971

AN - SCOPUS:70450159804

VL - 16

SP - 1318

EP - 1322

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 12

ER -